County
Lincoln County EMS
Drugs and doses52
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Bumetanide, Buprenorphine, Calcium Gluconate, Clopidogrel11
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | page 99 |
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | page 99 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 99 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 101 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 101 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 102 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 102 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 3 mg | NEB | not captured | standing | page 103 |
| Asthma / bronchospasm | peds | 3 mg | NEB | not captured | standing | page 103 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | page 103 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 103 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | page 104 |
| Other | adult | 150 mg | IV/IO | not captured | standing | page 104 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 104 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 104 |
| Wide-complex tachycardia | peds | 2.5 mg/kg | IV/IO | not captured | standing | page 104 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 104 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 104 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 105 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV/IO | not captured | standing | page 106 |
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 106 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 106 |
| Organophosphate poisoning | adult | 1–5 mg | IV/IO/IM | not captured | standing | page 106 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 106 |
Bumetanide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 1 mg | IV/IO/IM | not captured | standing | page 388 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 107 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–3 g | IV/IO | not captured | standing | page 108 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.6 mL/kg | IV/IO | not captured | standing | page 108 |
| Burns | adult | 3 g | TOP | not captured | standing | page 108 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | pages 62, 108 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | pages 42, 108 |
| Hyperkalemia | peds | 0.6 mL/kg | IV/IO | not captured | standing | pages 62, 108 |
Clopidogrel
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | PO | not captured | standing | page 390 |
D–F Dexamethasone, Dextrose, Diphenhydramine, Dopamine, Droperidol, Epinephrine, Etomidate, Fentanyl, Furosemide9
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 109 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 109 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 109 |
| Other | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 109 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 10–25 g | IV/IO | not captured | standing | page 110 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 110 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IM | not captured | standing | page 112 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 112 |
| Procedural sedation | peds | 1 mg/kg | IV/IM | not captured | standing | page 112 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2 mcg/kg | IV | not captured | standing | page 113 |
| Bradycardia | peds | 2 mcg/kg | IV | not captured | standing | page 113 |
| Cardiogenic shock | adult | 5 mcg/kg | IV | not captured | standing | page 113 |
| Cardiogenic shock | peds | 5 mcg/kg | IV | not captured | standing | page 113 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.625 mg | IV | not captured | standing | pages 114, 231 |
| Procedural sedation | adult | 2.5 mg | IV/IO | not captured | standing | pages 114, 231 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | pages 114, 158, 231 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 114, 158, 231 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 35, 36, 115 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 35, 36, 115 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 115 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 115 |
| Bradycardia | adult | 2–10 mcg | IV | not captured | standing | pages 46, 115 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 47, 115 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 42, 115, 292 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 42, 115, 292 |
| Hypotension / shock | adult | 10–20 mcg | IV/IO | not captured | standing | page 116 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.15 mg/kg | IV/IO | not captured | standing | pages 51, 52, 117 |
| Procedural sedation | peds | 0.15 mg/kg | IV/IO | not captured | standing | pages 51, 52, 117 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 117, 169, 170 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 117, 169, 170 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mcg | IV/IO | not captured | standing | pages 41, 118 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IM/IN | not captured | standing | pages 74, 75, 118 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IM/IN | not captured | standing | pages 74, 75, 118 |
| Post-intubation sedation | adult | 50–100 mcg | IV/IO | not captured | standing | pages 118, 170 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 118, 170 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20–40 mg | IV | not captured | standing | pages 81, 120 |
G–L Glucagon, Haloperidol, Heparin, Hydromorphone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam12
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg | IV/IM | not captured | standing | pages 35, 121 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 58, 121 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV/IM | not captured | standing | page 123 |
| Other | adult | 5–10 mg | IV/IO/IM | not captured | standing | page 123 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5000 unit | IV | not captured | standing | page 389 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.25–0.5 mg | IV | not captured | standing | page 124 |
| Mild to moderate pain | adult | 0.5–1 mg | IM | not captured | standing | page 124 |
| Mild to moderate pain | peds | 0.01 mg/kg | IV | not captured | standing | page 124 |
| Mild to moderate pain | peds | 0.01 mg/kg | IM | not captured | standing | page 124 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 g | IV/IO | not captured | standing | page 125 |
| Other | peds | 70 mg/kg | IV/IO | not captured | standing | page 125 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 200–600 mg | PO | not captured | standing | page 126 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 126 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 128 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 128 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 12.5–25 mg | IV/IO | not captured | standing | page 129 |
| Mild to moderate pain | adult | 25–50 mg | IM | not captured | standing | page 129 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 129 |
| Post-intubation sedation | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | page 129 |
| Post-intubation sedation | peds | 0.5–1 mg/kg | IV/IO | not captured | standing | page 129 |
| RSI induction | adult | 1–2 mg/kg | IV/IO | not captured | standing | page 129 |
| RSI induction | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 129 |
| Seizure | adult | 1 mg/kg | IV/IO | not captured | standing | page 129 |
| Seizure | adult | 2 mg/kg | IM | not captured | standing | page 129 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 131 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 131 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 131 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | page 131 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV | not captured | standing | pages 70, 132 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 133, 366, 375 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | pages 133, 366, 375 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | pages 133, 181, 182, 366, 375 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | pages 133, 181, 182, 366, 375 |
| Post-ROSC care | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 133, 366, 375 |
| Post-ROSC care | peds | 1.5 mg/kg | IV/IO | not captured | standing | pages 133, 366, 375 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5–1 mg | IV/IM | not captured | standing | pages 134, 231, 366 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 134, 135, 366 |
| Other | adult | 1–2 mg | IV/IO | not captured | standing | pages 134, 135, 366, 376 |
| Other | adult | 2 mg | IM | not captured | standing | pages 134, 135, 366, 376 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 134, 135, 366, 376 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | pages 134, 135, 366, 376 |
| Post-intubation sedation | adult | 1–2 mg | IV/IO | not captured | standing | pages 134, 135, 366, 376 |
| Post-intubation sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 134, 135, 366, 376 |
| Procedural sedation | adult | 2 mg | IV/IO | not captured | standing | pages 134, 135, 366, 376 |
| Procedural sedation | adult | 2 mg | IM | not captured | standing | pages 134, 135, 366, 376 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 134, 135, 366, 376 |
| Procedural sedation | peds | 0.05 mg/kg | IM | not captured | standing | pages 134, 135, 366, 376 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 134, 135, 366, 376 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | pages 134, 135, 366, 376 |
| Seizure | adult | 4 mg | IM | not captured | standing | pages 134, 135, 366, 376 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 134, 135, 366, 376 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 134, 135, 366, 376 |
M–O Magnesium Sulfate, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Olanzapine, Ondansetron, Oxymetazoline, Oxytocin10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 136, 367, 376 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | pages 136, 367 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | pages 136, 367 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 136, 367 |
| Other | adult | 2 g | IV | not captured | standing | pages 136, 367 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2.5 mg | IV/IO | not captured | standing | pages 137, 367 |
| Post-intubation sedation | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | adult | 2.5 mg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | adult | 5 mg | IM/IN | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | adult | 5 mg | IM/IN | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 137, 138, 367, 377 |
| Procedural sedation | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 137, 138, 367, 377 |
| RSI induction | adult | 5–10 mg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| RSI induction | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Seizure | adult | 10 mg | IM/IN | not captured | standing | pages 137, 138, 367, 377 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 137, 138, 367, 377 |
| Seizure | peds | 0.3 mg/kg | IM/IN | not captured | standing | pages 137, 138, 367, 377 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–8 mg | IV | not captured | standing | pages 139, 368, 377 |
| Mild to moderate pain | adult | 5–10 mg | IM | not captured | standing | pages 139, 368, 377 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV | not captured | standing | pages 139, 368, 377 |
| Mild to moderate pain | peds | 0.1 mg/kg | IM | not captured | standing | pages 139, 368, 377 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | IV | not captured | standing | pages 140, 368, 377 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 140, 368, 377 |
| Other | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 140, 368, 377 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 54, 141, 368 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 81, 141, 368 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 81, 141, 368 |
| Other | adult | 1 mg | IV | not captured | standing | pages 81, 141, 368 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mcg | IV | not captured | standing | pages 89, 90, 143, 368, 378 |
| Other | peds | 0.1 mcg/kg | IV | not captured | standing | pages 89, 90, 143, 368, 378 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 10 mg | ODT | not captured | standing | pages 31, 32, 33, 144, 368, 378 |
| Procedural sedation | peds | 2.5 mg | ODT | not captured | standing | pages 31, 32, 33, 144, 368, 378 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | pages 67, 145, 368, 378 |
| Nausea / vomiting | adult | 8 mg | PO | not captured | standing | pages 67, 145, 368, 378 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 67, 145, 368, 378 |
| Nausea / vomiting | peds | 2 mg | PO | not captured | standing | pages 67, 145, 368, 378 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | pages 59, 147, 368, 378 |
| Other | peds | 2 spray | IN | not captured | standing | pages 59, 147, 368, 378 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IV/IM | not captured | standing | pages 71, 148, 369 |
P–R Pralidoxime, Proparacaine, Rocuronium3
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1200 mg | IV/IM | not captured | standing | pages 149, 280, 369, 379 |
| Organophosphate poisoning | peds | 25–50 mg/kg | IV/IM | not captured | standing | pages 149, 280, 369, 379 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 1 drop | OPH | not captured | standing | pages 60, 150, 369 |
| Burns | peds | 1 drop | OPH | not captured | standing | pages 60, 150, 369 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IV/IO | not captured | standing | pages 151, 171, 369 |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 151, 171, 369 |
| RSI induction | adult | 1.2 mg/kg | IV/IO | not captured | standing | pages 151, 169, 369 |
| RSI induction | peds | 1.2 mg/kg | IV/IO | not captured | standing | pages 151, 169, 369 |
S–Z Sodium Bicarbonate, Sodium Thiosulfate, Succinylcholine, Ticagrelor, Tranexamic Acid, Vecuronium, Ziprasidone7
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | pages 152, 369 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 62, 152, 369 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 78, 152, 369 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 152, 369 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 96, 97, 152, 369 |
| Other | adult | 2.5 mL | NEB | not captured | standing | pages 78, 152, 369 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 78, 152, 369 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 152, 369 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 96, 97, 152, 369 |
| Other | peds | 2.5 mL | NEB | not captured | standing | pages 78, 152, 369 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 50 mL | IV | not captured | standing | pages 154, 369 |
| Cyanide poisoning | peds | 1.65 mL/kg | IV | not captured | standing | pages 154, 369 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 155, 169, 370, 379 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 155, 169, 370, 379 |
Ticagrelor
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 180 mg | PO | not captured | standing | page 387 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 2 g | IV/IO | not captured | standing | pages 156, 370, 380 |
| Obstetric hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 156, 370, 380 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 156, 370, 380 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 157, 171, 370, 380 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 157, 171, 370, 380 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 157, 169, 370, 380 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 157, 169, 370, 380 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 10–20 mg | IM | not captured | standing | pages 31, 32, 33, 158 |
| Procedural sedation | peds | 10 mg | IM | not captured | standing | pages 31, 32, 33, 158 |
Cite this
Lincoln County EMS, United States EMS Protocol Census. 199 dose entries, effective 2026-01-01.
https://protoquiz.com/census/agencies/lincoln-county-ems/
The census is free and not for sale. Only public agencies are named.